- Acromegaly
- Carcinoid syndrome
- Thyroid Tumours (Lanreotide)
Note; octreotide is a symptomatic treatment.
It is also used in reducing variceal bleeding and in reducing vomiting in palliative care, as unlicensed indications.
Octreotide and Lanreotide are long-acting somatostatin analogues. Somatostatin inhibits production of growth hormone and IGF-1, along with a range of other effects on the GI tract. It is therefore, treatment of choice in acromegaly and a range of endocrine tumours, assuming debulking pituitary surgery is not required.
Nil of note.
Patients and carers are given extensive input by endocrine nurses.
Nil of note.
